01—Abstract
Summary
Summary of the 8-K filed April 19, 2022. Cited figures are marked; the original filing is the authoritative source.
Agilent Technologies, Inc. has announced the entry into a new $600 milliona delayed draw term loan facility maturing in April 2025.
This facility is intended to refinance its outstanding 3.875%b Senior Notes due 2023, which are scheduled for redemption on May 4, 2022. The company expects to draw on the new loan facility around May 3, 2022, to facilitate this redemption. The new loan agreement includes customary covenants and events of default, with specific limitations on liens, subsidiary debt, and sale-leaseback transactions, as well as a financial covenant related to the ratio of adjusted consolidated financial indebtedness to consolidated capitalization.
This move indicates a strategic refinancing effort by Agilent, potentially to optimize its debt structure and manage interest expenses. While the new facility provides liquidity to retire existing debt, investors should monitor the company's debt levels and its ability to comply with the stipulated covenants. The interest rate on the new loan is variable, tied to either an alternate base rate or Adjusted Term SOFR, plus an applicable margin that depends on Agilent's credit ratings, currently set at 0.000%c for base rate loans and 0.750% for SOFR loans based on existing ratings.
02—Key points
Key Highlights
- Agilent entered into a $600 million delayed draw term loan agreement maturing April 15, 2025.
- The new loan facility is intended to fund the redemption of Agilent's $600 million 3.875% Senior Notes due 2023 on May 4, 2022.
- The company expects to draw on the term loan facility on or about May 3, 2022.
- The interest rate on the new loan can be based on an Alternate Base Rate or Adjusted Term SOFR, with applicable margins dependent on credit ratings.
- At current credit ratings, the applicable margin is 0.000% for Alternate Base Rate loans and 0.750% for Adjusted Term SOFR loans.
- The agreement includes customary covenants, such as limitations on liens, subsidiary debt, and sale-leaseback transactions, and a financial covenant on indebtedness to capitalization ratio (not to exceed 0.65:1.00).
03—Questions
Frequently Asked Questions
What is the purpose of the new $600 million term loan?
The primary purpose of the new $600 million delayed draw term loan facility is to provide the funds necessary to redeem Agilent's outstanding $600 million 3.875% Senior Notes due 2023, which is scheduled for May 4, 2022. This represents a refinancing of existing debt.
What are the interest rate terms for the new loan?
The interest rate can be based on either an Alternate Base Rate or Adjusted Term SOFR. The applicable margin varies based on Agilent's credit ratings. Currently, with Agilent's existing credit ratings, the applicable margin is 0.000% for Alternate Base Rate loans and 0.750% for Adjusted Term SOFR loans.
What are the key restrictions or covenants in the new loan agreement?
The Term Loan Agreement includes customary negative covenants that limit the incurrence of liens, indebtedness by subsidiaries, and sale-leaseback transactions, subject to certain exceptions. It also requires Agilent to maintain a ratio of adjusted consolidated financial indebtedness to consolidated capitalization not greater than 0.65 to 1.00.
When does Agilent expect to draw on this new loan facility?
Agilent expects to borrow under the Term Loan Agreement on or about May 3, 2022, to ensure funds are available for the redemption of its Senior Notes on May 4, 2022.
04—Continue